These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 26874740

  • 1. Multimodality imaging demonstrates trafficking of liposomes preferentially to ischemic myocardium.
    Lipinski MJ, Albelda MT, Frias JC, Anderson SA, Luger D, Westman PC, Escarcega RO, Hellinga DG, Waksman R, Arai AE, Epstein SE.
    Cardiovasc Revasc Med; 2016 Mar; 17(2):106-12. PubMed ID: 26874740
    [Abstract] [Full Text] [Related]

  • 2. Regional contrast agent quantification in a mouse model of myocardial infarction using 3D cardiac T1 mapping.
    Coolen BF, Geelen T, Paulis LE, Nicolay K, Strijkers GJ.
    J Cardiovasc Magn Reson; 2011 Oct 05; 13(1):56. PubMed ID: 21974927
    [Abstract] [Full Text] [Related]

  • 3. Distribution of lipid-based nanoparticles to infarcted myocardium with potential application for MRI-monitored drug delivery.
    Paulis LE, Geelen T, Kuhlmann MT, Coolen BF, Schäfers M, Nicolay K, Strijkers GJ.
    J Control Release; 2012 Sep 10; 162(2):276-85. PubMed ID: 22771978
    [Abstract] [Full Text] [Related]

  • 4. Early Gadolinium Enhancement for Determination of Area at Risk: A Preclinical Validation Study.
    Hammer-Hansen S, Leung SW, Hsu LY, Wilson JR, Taylor J, Greve AM, Thune JJ, Køber L, Kellman P, Arai AE.
    JACC Cardiovasc Imaging; 2017 Feb 10; 10(2):130-139. PubMed ID: 27665165
    [Abstract] [Full Text] [Related]

  • 5. AUR Memorial Award. Identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging.
    Geschwind JF, Wendland MF, Saeed M, Lauerma K, Derugin N, Higgins CB.
    Acad Radiol; 1994 Dec 10; 1(4):319-25. PubMed ID: 9419506
    [Abstract] [Full Text] [Related]

  • 6. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents.
    Schwitter J, Saeed M, Wendland MF, Derugin N, Canet E, Brasch RC, Higgins CB.
    J Am Coll Cardiol; 1997 Oct 10; 30(4):1086-94. PubMed ID: 9316544
    [Abstract] [Full Text] [Related]

  • 7. Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats.
    Takahama H, Minamino T, Asanuma H, Fujita M, Asai T, Wakeno M, Sasaki H, Kikuchi H, Hashimoto K, Oku N, Asakura M, Kim J, Takashima S, Komamura K, Sugimachi M, Mochizuki N, Kitakaze M.
    J Am Coll Cardiol; 2009 Feb 24; 53(8):709-17. PubMed ID: 19232905
    [Abstract] [Full Text] [Related]

  • 8. Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy.
    Wolfe CL, Moseley ME, Wikstrom MG, Sievers RE, Wendland MF, Dupon JW, Finkbeiner WE, Lipton MJ, Parmley WW, Brasch RC.
    Circulation; 1989 Oct 24; 80(4):969-82. PubMed ID: 2791255
    [Abstract] [Full Text] [Related]

  • 9. Validation of contrast enhanced cine steady-state free precession and T2-weighted CMR for assessment of ischemic myocardial area-at-risk in the presence of reperfusion injury.
    Hansen ESS, Pedersen SF, Pedersen SB, Bøtker HE, Kim WY.
    Int J Cardiovasc Imaging; 2019 Jun 24; 35(6):1039-1045. PubMed ID: 30852704
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Distribution of intracellular, extracellular, and intravascular contrast media for magnetic resonance imaging in hearts subjected to reperfused myocardial infarction.
    Wendland MF, Saeed M, Geschwind JF, Mann JS, Brasch RC, Higgins CB.
    Acad Radiol; 1996 Aug 24; 3 Suppl 2():S402-4. PubMed ID: 8796614
    [No Abstract] [Full Text] [Related]

  • 12. An interleaved T1-T2* imaging sequence for assessing myocardial injury.
    Tian G, Shen JF, Dai G, Sun J, Xiang B, Luo Z, Somorjai R, Deslauriers R.
    J Cardiovasc Magn Reson; 1999 Aug 24; 1(2):145-51. PubMed ID: 11550347
    [Abstract] [Full Text] [Related]

  • 13. Targeting Endothelin Receptors in a Murine Model of Myocardial Infarction Using a Small Molecular Fluorescent Probe.
    Kimm MA, Haas H, Stölting M, Kuhlmann M, Geyer C, Glasl S, Schäfers M, Ntziachristos V, Wildgruber M, Höltke C.
    Mol Pharm; 2020 Jan 06; 17(1):109-117. PubMed ID: 31816245
    [Abstract] [Full Text] [Related]

  • 14. Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction.
    Dasa SSK, Suzuki R, Gutknecht M, Brinton LT, Tian Y, Michaelsson E, Lindfors L, Klibanov AL, French BA, Kelly KA.
    J Control Release; 2015 Dec 28; 220(Pt A):556-567. PubMed ID: 26122651
    [Abstract] [Full Text] [Related]

  • 15. Monocyte and/or macrophage infiltration of heart after myocardial infarction: MR imaging by using T1-shortening liposomes.
    Naresh NK, Xu Y, Klibanov AL, Vandsburger MH, Meyer CH, Leor J, Kramer CM, French BA, Epstein FH.
    Radiology; 2012 Aug 28; 264(2):428-35. PubMed ID: 22723500
    [Abstract] [Full Text] [Related]

  • 16. Passive targeting of lipid-based nanoparticles to mouse cardiac ischemia-reperfusion injury.
    Geelen T, Paulis LE, Coolen BF, Nicolay K, Strijkers GJ.
    Contrast Media Mol Imaging; 2013 Aug 28; 8(2):117-26. PubMed ID: 23281284
    [Abstract] [Full Text] [Related]

  • 17. MR imaging of contrast-enhanced porcine myocardial infarction. Assessment of reperfusion and tissue viability.
    Nilsson S.
    Acta Radiol Suppl; 1995 Aug 28; 397():1-44. PubMed ID: 7484207
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mapping myocardial viability using interleaved T1-T2* weighted imaging.
    Li G, Dai G, Xiang B, Mark J, Tomanek B, Liu H, Deslauriers R, Tian G.
    Int J Cardiovasc Imaging; 2004 Apr 28; 20(2):135-43. PubMed ID: 15068145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.